Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 5;19(2):913–922. doi: 10.3892/etm.2019.8285

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Huang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 6. — Effect of heparin on anti-coagulation and fibrinolysis parameters in an LPS-induced sepsis rat model. (A) AT and (C) PAI-1 were determined using an ELISA at 0.5, 2 and 6 h after LPS injection, respectively. Effect of UFH or NAH on (B) AT and (D) PAI-1 in plasma at 2 and 6 h after LPS injection. Data are presented as mean ± standard deviation. There were 6 animals in each group at 0.5, 2 and 6 h, respectively. *P<0.05 vs. the control group; ^#P<0.05 vs. the LPS group. The AT data were analyzed using a Kruskal-Wallis test along with Bonferroni correction. The PAI-1 data were analyzed using a one-way analysis of variance followed by a Student-Newman-Keuls test for multiple group comparisons. LPS, lipopolysaccharide; AT, antithrombin; PAI-1, plasminogen activator inhibitor-1; UFH, unfractionated heparin; NAH, N-acetylheparin.